Search for other papers by Ali Abbara in
Google Scholar
PubMed
Search for other papers by Sophie Clarke in
Google Scholar
PubMed
Search for other papers by Pei Chia Eng in
Google Scholar
PubMed
Search for other papers by James Milburn in
Google Scholar
PubMed
Search for other papers by Devavrata Joshi in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Alexander N Comninos in
Google Scholar
PubMed
Search for other papers by Rozana Ramli in
Google Scholar
PubMed
Search for other papers by Amrish Mehta in
Google Scholar
PubMed
Search for other papers by Brynmor Jones in
Google Scholar
PubMed
Search for other papers by Florian Wernig in
Google Scholar
PubMed
Search for other papers by Ramesh Nair in
Google Scholar
PubMed
Search for other papers by Nigel Mendoza in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Amir H Sam in
Google Scholar
PubMed
Search for other papers by Emma Hatfield in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Waljit S Dhillo in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Niamh M Martin in
Google Scholar
PubMed
/13 – – – Medications on discharge from hospital following admission for apoplexy Glucocorticoid replacement 18/18 12/12 – – – Levothyroxine 9/18 6/12 – – – Dopamine agonist 1/18 0/12 – – – Desmopressin 1
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Search for other papers by Mira Jakovcevski in
Google Scholar
PubMed
with conventional hydrocortisone usually divided into 2–3 doses per day. Secondary hypothyroidism was treated with levothyroxine. Gonadotropic insufficiency was treated with testosterone in men (in form of transdermal gel or intramuscular injections
Search for other papers by Stephanie Burger-Stritt in
Google Scholar
PubMed
Search for other papers by Linda Bachmann in
Google Scholar
PubMed
Search for other papers by Max Kurlbaum in
Google Scholar
PubMed
Search for other papers by Stefanie Hahner in
Google Scholar
PubMed
study procedures, all further long-term medication (including fludrocortisone and levothyroxine) was ingested as usual by the patients. Six patients initially received the PN suppository vaginally and six patients rectally. The minimum time interval
Search for other papers by Norra Kwong in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Michael S Gordon in
Google Scholar
PubMed
Search for other papers by P Reed Larsen in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Jeffrey R Garber in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
-progressive nature of persistent, lung metastases following initial surgical therapy and 131 I ablation. Levothyroxine-suppressive therapy was provided to all patients, with a goal TSH <0.1 mIU/l. Subject no. Age at diagnosis Sites of distant metastases 131 I
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Georgios Kontogeorgos in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Zoi Mamasoula in
Google Scholar
PubMed
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Emily Krantz in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Penelope Trimpou in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Kerstin Landin-Wilhelmsen in
Google Scholar
PubMed
Endocrine Out-Patient Clinic, Carlanderska Hospital, Gothenburg, Sweden
Search for other papers by Christine M Laine in
Google Scholar
PubMed
patients with postoperative HypoPT were older, used higher doses of daily calcium supplementation, and used levothyroxine more often than those with HypoPT of other causes, n = 40. No other significant differences were seen in biochemical analyses, BMI
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Henrik Falhammar in
Google Scholar
PubMed
radioactive iodine, where thyrocytes are exposed to local radiation, with a subsequent decline of hormone secretion. In these two latter alternatives hypothyroidism is a deliberate goal, treated by life-long levothyroxine. Pharmacologic therapy is often
Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed
Search for other papers by Iwona Pałyga in
Google Scholar
PubMed
Search for other papers by Monika Szymonek in
Google Scholar
PubMed
Search for other papers by Artur Kowalik in
Google Scholar
PubMed
Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed
Search for other papers by Anna Słuszniak in
Google Scholar
PubMed
Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed
Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed
Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
), the levothyroxine (LT 4 ) dose was adjusted by the general practitioner to ensure that TSH levels were within the recommended range for the patient. Investigations From 2000 until 2007, Tg concentrations were evaluated using a chemiluminescent
Search for other papers by C E Higham in
Google Scholar
PubMed
The University of Liverpool, Brownlow Hill, Liverpool, UK
Search for other papers by A Olsson-Brown in
Google Scholar
PubMed
Search for other papers by P Carroll in
Google Scholar
PubMed
Search for other papers by T Cooksley in
Google Scholar
PubMed
Search for other papers by J Larkin in
Google Scholar
PubMed
Search for other papers by P Lorigan in
Google Scholar
PubMed
Search for other papers by D Morganstein in
Google Scholar
PubMed
Search for other papers by P J Trainer in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
eye disease (CAS (Clinical Activity Score) >3 or evidence of optic nerve compression) should be referred urgently to ophthalmology/local thyroid eye service. Levothyroxine should never be instigated until co-existent cortisol deficiency is
Search for other papers by Huixing Liu in
Google Scholar
PubMed
Search for other papers by Daoquan Peng in
Google Scholar
PubMed
increase of cholesterol levels was closely related to declined TH levels after injection of TSH in levothyroxine-treated thyroidectomized patients ( 31 ). TSH alone also can increase TC levels in CVD patients independent of TH ( 32 ). It has been reported
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
Search for other papers by Martin Krššák in
Google Scholar
PubMed
Search for other papers by Michael Krebs in
Google Scholar
PubMed
Winhofer Y Duan H Einwallner E Gessl A Luger A Trattnig S Hoffmann M Niessner A Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function . Journal of Clinical Endocrinology